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Case Report
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Mixed connective tissue disease (MCTD), also known as “overlaps syndrome,” is an autoimmune disorder with an overlap of rheumatoid arthritis (RA), polymyositis, 
systemic sclerosis (SSc), and systemic lupus erythematosus 
(SLE). MCTD has a high titer of a specific antibody anti-U1 
ribonucleoprotein (U1RNP) in their serum. It was first described by 
Sharp et al., in 1972 [1]. The prevalence of MCTD is 1.9/100,000 
population per year (3.1/100,000 population among females and 
0.7/100,000 population among males) [2,3]. Prevalence is high in 
females than in males and the F: M ratio varies from 3:1 to 16:1 [3]. 
The onset of MCTD can occur anytime from early childhood to 
elderly adulthood, but the average age of onset is 37 years [4].
MCTD is quite rarely reported in India. The patients usually 
present with mixed clinical findings of SLE, RA, polymyositis, 
and SSc. Definite diagnostic criteria have been put forth. Our case 
was unique as the patient presented predominantly as weakness in 
all four limbs and clinical examination revealed features of other 
disorders.
CASE REPORT
A 45-year-old woman presented to us with weakness in all four 
limbs for 2 months. She noticed weakness in her proximal lower 
limbs in the form of difficulty in getting up from squatting position 
and climbing stairs associated with pain in thighs. After 2 weeks of 
lower limb involvement, the weakness involved proximal upper 
limbs in the form of difficulty in combing hair and reaching to the 
objects above shoulder level while working in the kitchen. There 
was no history of involvement of the distal muscles, back pain, 
neck pain, tingling in extremities, paresthesia, bladder bowel 
involvement, blurring of vision, vomiting, and fever. On asking 
leading questions, there was a history of arthralgia involving large 
and small joint for 7 months and morning stiffness lasting >1 h in 
the hand joints for 4 months along with Raynaud’s phenomenon. 
For these complaints, the patient visited a local practitioner and 
was treated with intermittent painkillers and calcium supplements.
On clinical examination, vitals were normal 
(pulse=80/min regular, BP was 110/70 mmHg, and respiratory 
rate=16 breaths/min). Her oxygen saturation was 99% while 
breathing ambient air. There were no signs of icterus, clubbing, 
cyanosis, and lymphadenopathy. The jugular venous pressure 
was 4 cm of water at 45° and edema was absent. Oral cavity 
examination revealed multiple oral ulcers.
She had a puckered face (Fig. 1) and pinching of skin was 
not possible. Musculoskeletal and dermatological examination 
revealed stiffness in small joint and sclerodactyly (Fig. 2). 
Neurological examination revealed normal higher functions 
and cognition, no cranial nerve abnormality. In motor system 
examination, power was 5/5 in the distal upper and lower limb 
and 3/5 in proximal muscles of upper and lower limb. There was 
palpable tenderness in both deltoids, quadriceps, and hamstrings. 
Deep tendon reflexes were normal and planters were bilateral 
flexors. Sensory examination was normal. On the background 
of sclerodactyly and muscle weakness with joint involvement, a 
possibility of MCTD was kept and she was investigated.
Investigations revealed hemoglobin - 8.9 g% and normocytic 
normochromic RBC. Total and differential leukocyte counts 
were within normal limits. Erythrocyte sedimentation rate was 
68 mm in the 1st h. A spot urine albumin-to-creatinine ratio was 
68 mg albumin per gram creatinine (20–200 mg/g). Rheumatoid 
factor (RA) was positive, antinuclear antibody (ANA) was 
positive (122.92 IU/ml) with speckled pattern, and U1RNP 
antibody was strongly positive, 1217.36 units by ELISA (>80 
strongly positive). The hemagglutination titer of U1RNP was 
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1:1732 (>1:1600). Creatinine phosphokinase (CPK) was raised 
at 4614 IU (21–192 IU). Electromyography (EMG) showed 
myopathic potentials. X-rays of the hands showed periarticular 
osteopenia and synovitis (Fig. 3). A muscle biopsy was obtained 
from the quadriceps muscle, and histopathologic slide was 
made which shows the features of degenerating fibers, necrotic 
fibers, and internalization of nuclei, suggestive of polymyositis 
(Fig. 4). Her barium swallow, upper gastrointestinal endoscopy, 
and gastrointestinal endoscopy were normal. All the clinical and 
laboratory findings of our patient were shown in Table 1.
A final diagnosis of subacute onset, gradually progressive 
lower motor neuron quadriparesis due to polymyositis was made. 
Most likely, overlap syndrome was kept and the diagnosis was 
confirmed using diagnostic criteria of MTCD.
The patient was started on pulse methylprednisolone therapy 
at a dose of 1000 mg per day for 3 days and started on tablet 
prednisolone 40 mg/day from the 4th day. Tablet methotrexate was 
added at a dose of 15 mg/week as add-on immunosuppressant 
and tablet amlodipine 5 mg per day was added for Raynaud’s 
phenomenon. After 2 weeks, CPK levels decreased, pain in 
muscle decreased, and the power of the muscle increased to 4/5. 
The dose of corticosteroids was tapered over next 3 weeks to a 
maintenance dose of 10 mg/day, and tablet methotrexate was 
continued with folic acid supplement. The patient is awaiting 
subsequent follow-up.
DISCUSSION
MCTD is a rare autoimmune condition affecting almost all organs 
of the body with a majority of the patients being female [3]. This 
condition presents with overlapping features of other connective 
tissue diseases such as SLE, polymyositis, sclerosis, and RA. The 
major diagnostic criterion for MCTD is raised titer of ANA (anti-
U1RNP antibody). The term overlap syndrome has been described 
for the patients who have signs of two or more connective tissue 
disease simultaneously.
The immunopathology of the development of MCTD is 
complex as both the innate and adaptive immune system play 
role. Structural modifications of antigens occur during apoptosis 
and subtle immunogenic alterations drive the self-antigens 
to become immunogenic. There is also an overproduction 
of immunoglobulin-G autoantibodies which are directed 
against select components of the spliceosome. Evidence 
also prove that B-lymphocyte activation, and CD4 and CD8 
T-lymphocyte participation occur in the process. B-lymphocyte 
Figure 2: Stiffness in small joint and sclerodactyly
Figure 3: Periarticular osteopenia with synovitis
Figure 4: Histopathologic slide showing degenerating fibers 
(short arrow), necrotic fibers (long arrow), and internalization of 
nuclei features suggestive of polymyositis (arrow tip)
Figure 1: Puckered face
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hyperactivity results in high levels of anti-U1RNP and 
anti-U1-70 kd autoantibodies. T-lymphocyte activation produces 
anti-U1-70 kd - reactive T-lymphocytes. A genetic association has 
also been confirmed to be associated with major histocompatibility 
genes human leukocyte antigen (HLA)-DRB1*04/*15 [5,6].
The differential diagnosis of MCTD is SLE, RA, scleroderma/
SSc, polymyositis and dermatomyositis, idiopathic pulmonary 
arterial hypertension, and Raynaud’s phenomena. Different 
diagnostic criteria have been laid down for MCTD. These are by 
Sharp, Alarcón-Segovia, Kasukawa, and Kahn. A comparative 
study among all these criteria showed that the Alarcón-Segovia 
criteria, which have 62.5% sensitivity and 86.2% specificity, 
more accurately diagnose MCTD. The Kahn criteria also have a 
better diagnostic accuracy [7].
The Alarcon-Segovia diagnostic criteria consist of a positive 
anti-U1RNP titer (>1:1600) and at least three of the following 
five clinical findings: Hand edema, synovitis, biologically or 
histologically proven myositis, Raynaud phenomenon, and 
acrosclerosis with or without proximal SSc [7,8]. Our patient 
satisfies the following Alarcon-Segovia diagnostic criteria 
(positive anti-U1RNP, myositis in histopathology examination, 
Raynaud phenomena, and SSc). The Khan criteria [7,8] were as 
follows: Serologic - high titer of anti-U1RNP corresponding to 
a speckled ANA of >1:1200 titer and clinical - swollen fingers, 
synovitis, myositis, and Raynaud’s phenomena. The final 
diagnosis is based on serologic criteria, Raynaud’s phenomena, 
and any two of the remaining three clinical criteria. Our patient 
also satisfied Kahn criteria (serologic+Raynaud phenomena, 
synovitis, and myositis).
Although MCTD is incurable, drugs are given to control 
the signs and symptoms and modify the disease pathology to 
improve the quality of life. It is usually treated with nonsteroidal 
anti-inflammatory drugs for pain relief, corticosteroids for the 
reduction of inflammation, and disease-modifying antirheumatic 
agents such as hydroxychloroquine, methotrexate, and 
cyclophosphamide are used. Pulmonary hypertension is treated 
with Bosentan, Raynaud’s phenomenon is treated with calcium 
channel blockers like amlodipine [9-11]. Our case had myositis 
and myopathy so pulse methylprednisolone therapy was given.
CONCLUSION
MCTD is a rare form of an autoimmune disease which involves 
each organ system and overlaps between four different autoimmune 
diseases. Different diagnostic criteria have been published. Among 
all, Alarcon-Segovia and Kahn’s criteria are widely used. Treatment 
is usually done for the symptoms, and disease-modifying drugs are 
used to quiescent the immunopathologic progression.
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Table 1: All the clinical and laboratory findings of our 
patient (laboratory values mentioned in text)
SLE-like symptoms Polyarthritis, thrombocytopenia, ANA 
positive, oral ulcers, and proteinuria
Polymyositis-like 
findings
Proximal muscle weakness, myogenic 
pattern on EMG, elevated levels of muscles 
enzymes (CPK), and histopathologic 
evidence
Rheumatoid arthritis 
like findings
Morning stiffness, arthralgia, rheumatoid 
factor positive, and X-ray hands; osteopenia 
and synovitis
Scleroderma-like 
findings
Sclerodactyly, pulmonary function test shows 
restrictive pattern
EMG: Electromyography, SLE: Systemic lupus erythematosus, CPK: Creatinine 
phosphokinase, ANA: Antinuclear antibody
